Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles

PURPOSE: Lung cancer is the leading cause of cancer mortality worldwide. Drug resistance is the major barrier for the treatment of non-small cell lung cancer (NSCLC). The aim of this research is to develop an aptamer-decorated hybrid nanoparticle for the co-delivery of docetaxel prodrug (DTXp) and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ruifeng, Zhang, Zhiqiang, Wang, Baohua, Chen, Ge, Zhang, Yaozhong, Deng, Haowen, Tang, Zilong, Mao, Junjie, Wang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293388/
https://www.ncbi.nlm.nih.gov/pubmed/32606595
http://dx.doi.org/10.2147/DDDT.S246574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293388/
https://www.ncbi.nlm.nih.gov/pubmed/32606595
http://dx.doi.org/10.2147/DDDT.S246574

Ejemplares similares